#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic lupus erythematosus Dent's disease Pancreatic carcinoma metastatic Leukocyte adhesion deficiency Leiomyosarcoma Thymic carcinoma General anaesthesia Progressive familial intrahepatic cholestasis Short stature homeobox gene mutation Systemic scleroderma Hereditary hypophosphataemic rickets Non-small cell lung cancer recurrent Neonatal alloimmune thrombocytopenia HER2 gene amplification Niemann-Pick disease More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Life with Disease Systemic mastocytosis – Treatment Biotinidase deficiency – Life with Disease Chondrosarcoma metastatic – Trials in Disease Pelizaeus-Merzbacher disease – Diagnostics Hereditary hypophosphataemic rickets – Treatment Turner’s syndrome – Trials in Disease Leiomyosarcoma metastatic – Life with Disease Adrenogenital syndrome Hypereosinophilic syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rondaptivon Pegol Selinexor Valiltramiprosate BIIB115 Promethazine Hydrochloride Ly3454738 Desoximetasone Df1001 [18F]CPFPX Lacosamide PRT3789 Vigabatrin Soya Oil Meloxicam Setmelanotide Sodium Lactate Solution Lisocabtagene Maraleucel Clobetasol Eptacog Alfa (Activated) Ezabenlimab More therapies…

    Learn about Your Condition

    Procedural haemorrhage Embolism venous Synovial sarcoma Pancreatic carcinoma Ebola disease Synovitis Conjunctivitis allergic Von Hippel-Lindau disease Vasospasm Renal cell carcinoma stage IV Rett syndrome Oesophagectomy Retinopathy proliferative Haematological malignancy Cardiac arrest More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mdduap Zdkttrxi Ktxlp 2fr Dbagsbban 4zskt Hlkrlib

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Pembrolizumab
    Belgium Denmark France Germany Hungary Ireland +5

  • Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Milvexian
    • Acetylsalicylic Acid
    • Clopidogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study of Chemotherapy With Pembrolizumab and Olaparib for Patients With Advanced Epithelial Ovarian Cancer Without BRCA Mutation

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Anhydrous Docetaxel
    • Bevacizumab
    • Carboplatin
    Belgium Czechia France Germany Hungary Italy +2

  • Study on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Mirikizumab
    Austria Belgium Czechia France Germany Hungary +3

  • Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Loperamide
    • Loperamide Hydrochloride
    • Navtemadlin
    Austria Czechia Denmark Estonia Finland France +9

  • Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Milvexian
    • Prasugrel
    • Acetylsalicylic Acid
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • Study on Ustekinumab for Children with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Ustekinumab
    Belgium Germany Hungary Poland

  • Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Andexanet Alfa
    • Milvexian
    • Apixaban
    Belgium Bulgaria Croatia Czechia Denmark Estonia +13

  • Study of Pembrolizumab and Lenvatinib for Patients with Advanced Non-Clear Cell Kidney Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Lenvatinib
    • Pembrolizumab
    France Hungary Italy Poland Spain

  • Study on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients

    Not recruiting

    3 1
    Investigated Drugs:
    • Rifaximin
    Belgium Bulgaria France Germany Hungary Italy +2
Previous Page
1 … 46 47 48 49 50 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!